Adaptive Biotechnologies Corp — Director's Dealing 2020

Sep 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2020-09-15

Reporting Person: HERSHBERG ROBERT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-15	Common Stock	M	2000	$0.45	Acquired	2000	Direct
2020-09-15	Common Stock	S	2000	$42.58	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-15	Stock Option (Right to Buy)	$0.45	M	2000	Disposed	2023-02-04	Common Stock (2000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020.

F2: The option is fully vested and exercisable.